- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00309517
Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C
March 31, 2006 updated by: Austrian Breast & Colorectal Cancer Study Group
A Prospectively Randomized Study on Neoadjuvant Radio-Chemotherapy in Patients With Operated Rectal Carcinoma Dukes B and C (pT2, pN1-3; pT3-4, pN0-3; M0.
This clinical investigation examined the influence of preoperative radiotherapy in combination with postoperative 5-fluorouracil + leucovorin chemotherapy vs. 5-fluorouracil + leucovorin + MAb 17-1A chemo-immunotherapy on patients' local recurrence rate and overall survival time following surgery for rectal carcinoma Dukes B or C (T2-4, N0-3, M0).
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment
700
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vienna, Austria, 1090
- Medical University of Vienna, General Hospital
-
-
Burgenland
-
Oberpullendorf, Burgenland, Austria, 7350
- Hospital Oberpullendorf
-
-
Lower Austria
-
Baden bei Wien, Lower Austria, Austria, 2500
- Hospital Baden
-
Hainburg, Lower Austria, Austria, 2410
- Hospital Hainburg
-
Wiener Neustadt, Lower Austria, Austria, 2700
- Hospital Wiener Neustadt, Surgery
-
-
Styria
-
Graz, Styria, Austria, 8036
- Medical University of Graz, Oncology
-
-
Upper Austria
-
Linz, Upper Austria, Austria, 4020
- General Hospital Linz
-
Linz, Upper Austria, Austria, 4020
- Hospital BHB Linz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with histologically verified operable rectal cancer Dukes B and C (Stage II, T2-4, N0-3, M0), R0
- Age: 18-80 years
- Karnofsky Performance Status > 80
- Adequate bone marrow reserve (leukocytes > 4,000, thrombocytes > 105/mm3, Hb > 10g %), renal and hepatic functions (total bilirubin and creatinine < 1.25 x ULN)
Exclusion Criteria:
- Colon cancer
- R1, R2; carcinosis peritonei
- Start of treatment > 42 days postop; other adjuvant radiotherapy, chemotherapy or immunotherapy
- Previous application of a murine or chimeric monoclonal antibody or antibody fragment
- Medical therapy with steroids, cyclosporin or antithymocyte globulin within 3 months pre-study
- Known hypersensitivity to animal protein
- Serious concomitant disease: HIV, chronically inflammatory intestine, diabetes mell. gravis, cerebral seizure disorder, et al.
- Pregnancy or lactation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Overall survival
|
Local recurrence-free survival
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 1997
Study Registration Dates
First Submitted
March 31, 2006
First Submitted That Met QC Criteria
March 31, 2006
First Posted (Estimate)
April 3, 2006
Study Record Updates
Last Update Posted (Estimate)
April 3, 2006
Last Update Submitted That Met QC Criteria
March 31, 2006
Last Verified
October 1, 2000
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms
- Neoplasms by Site
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Intestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Colorectal Neoplasms
- Rectal Neoplasms
- Physiological Effects of Drugs
- Immunologic Factors
- Protective Agents
- Micronutrients
- Adjuvants, Immunologic
- Vitamins
- Antidotes
- Vitamin B Complex
- Leucovorin
- Edrecolomab
Other Study ID Numbers
- ABSCG 92
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rectal Cancer Dukes B, Dukes C
-
Ohio State University Comprehensive Cancer CenterCompletedRecurrent Colon Cancer | Recurrent Rectal Cancer | Stage IV A Bladder Cancer | Stage IV A Rectal Cancer | Stage IV B Colon Cancer | Stage IV B Rectal CancerUnited States
-
Kindai UniversityUnknownChronic Hepatitis B | Chronic Hepatitis CJapan
-
Cardiff UniversityRecruitingAnal Cancer Stage III A | Anal Cancer Stage III BUnited Kingdom, Norway
-
Armando Santoro, MDCompletedColorectal Cancer Metastatic | C-met OverexpressionItaly
-
Fudan UniversityRecruitingColorectal Cancer | Vitamin C | GLUT3China
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedHepatitis C Virus Infection | Colorectal CancerUnited States
-
Institut National de la Santé Et de la Recherche...Not yet recruitingViral Hepatitis C | Liver Cancer | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Chronic Liver Disease and Cirrhosis | Viral Hepatitis B | Viral Hepatitis D
-
Chinese PLA General HospitalRecruitingBCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular CarcinomaChina
-
University Hospital, MontpellierNot yet recruitingHepatocellular Carcinoma | Liquid Biopsy | BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular Carcinoma | Immune Checkpoint Inhibitor
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAdvanced Adult Hepatocellular Carcinoma | Advanced Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma | BCLC Stage B Adult Hepatocellular Carcinoma | BCLC Stage C Adult Hepatocellular CarcinomaUnited States
Clinical Trials on Leucovorin
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompletedColorectal NeoplasmsJapan
-
Royal Marsden NHS Foundation TrustMerck Serono International SATerminated
-
National Taiwan University HospitalMackay Memorial Hospital; Taipei Veterans General Hospital, Taiwan; National... and other collaboratorsCompleted
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Mackay Memorial Hospital; Taipei Veterans... and other collaboratorsTerminatedNasopharyngeal CarcinomaTaiwan
-
Marks, John, M.D.TerminatedRectal NeoplasmsUnited States
-
Fudan UniversityUnknown
-
National Health Research Institutes, TaiwanMackay Memorial Hospital; China Medical University Hospital; Chang Gung Memorial... and other collaboratorsUnknownAdenocarcinoma | Colonic DiseasesTaiwan
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; National Cheng-Kung University HospitalUnknownPancreatic Cancer
-
Zealand University HospitalRecruitingIntestinal Neoplasms | Colorectal Cancer | Rectal Cancer | Rectal Neoplasms | Colorectal Neoplasm | Chemotherapy Effect | Intestinal DiseaseDenmark
-
AIO-Studien-gGmbHServierCompletedCholangiocarcinoma Non-resectable | Cholangiocarcinoma of the Gallbladder | Cholangiocarcinoma Metastatic | Cholangiocarcinoma AdvancedGermany